Precision BioSciences Inc. – Filings and Transcripts

NASDAQ: DTIL
Share price (3/24/26): $6.40
Market cap (3/24/26): $158 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Ownership Filter

Amoroso Michael

Kelly John Alexander

Smith J. Jefferson

Smith J. Jefferson

News Filter

Investor Presentation

Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update

Receives U.S. FDA Clearance of Investigational New Drug Application for First-In-Class PBGENE-DMD for Treatment of Duchenne Muscular Dystrophy

Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy

Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC